Sanne de Jongh - Gilde Healthcare

team
Venture&Growth

All team members
Sanne de Jongh
Investment Manager Therapeutics
Venture&Growth
The Netherlands

Sanne de Jongh

Investment Manager - Therapeutics
Venture&Growth

Sanne de Jongh joined Gilde Healthcare in 2017 and focuses on the biopharmaceutical sector. She is involved in deal sourcing, assessment of investment cases and portfolio management. She represents Gilde on the board of Calypso Biotech B.V. and ADCendo ApS.

Prior to joining Gilde, Sanne was with Anterra Capital for three years, a global food and ag tech fund backed by Fidelity and Rabobank. Here she worked on several biotech investments, such as Caribou Biosciences (IPO on Nasdaq: CRBU), Enko Chem and Agrimetis.

She began her career at MS Ventures, the biopharma fund of Merck KGaA, where she reviewed early stage strategic investments and supported the portfolio companies.

Sanne earned a masters degree (cum laude) in Biochemistry from Delft University of Technology, with a specialization in Neurology at the LUMC, the Netherlands. She is a Dutch citizen based in Gilde’s Utrecht office.

Dan Secor

Associate Healthtech
Venture&Growth
Dan Secor joined Gilde Healthcare in 2020 in the Cambridge office and focuses on the Healthtech sector. He was part of Gilde’s investment team in Eargo, where he served as a board observer. Before joining...

Professor Dr. Rene Bernards

Operational Partner
Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute...

Marc Olivier Perret

Managing Partner
Marc Olivier Perret is founder and managing partner of Gilde Healthcare. Marc Olivier joined Gilde in 2000 following a 17 year career at Novartis (initially Ciba-Geigy) during which he gained operational and international experience in...